Synthesis and evaluation of potent and selective β3 adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres

被引:48
|
作者
Uehling, DE [1 ]
Donaldson, KH
Deaton, DN
Hyman, CE
Sugg, EE
Barrett, DG
Hughes, RG
Reitter, B
Adkison, KK
Lancaster, ME
Lee, F
Hart, R
Paulik, MA
Sherman, BW
True, T
Cowan, C
机构
[1] GlaxoSmithKline, Dept Med Chem, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline, Dept Res Bioanal & Drug Metab, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline, Dept Pharmacol, Res Triangle Pk, NC 27709 USA
[4] GlaxoSmithKline, Dept Receptor Biol, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1021/jm0101500
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Starting from phenethanolamine aniline leads 3a and 3b, we have identified a series of functionally potent and selective beta(3) adrenergic receptor (AR) agonists containing acylsulfonamide, sulfonylsulfonamide, or sulfonylurea groups within the aniline phenethanolamine series. In beta(3) beta(2), and beta(1) AR cAMP functional assays, 3a and other right-hand side (RHS) carboxylate analogues were found to be full agonists that were modestly selective against beta(1) or beta(2) ARs, while analogues lacking RHS acid functionality were active at beta(3) AR but not selective. Replacement of the carboxylate with acylthiazole and acylmethylsulfone gave potent, but only modestly selective, compounds. Increasing the size of the RHS sulfonamide substituent with phenyl or p-toluene afforded compounds with good potency and functional selectivity (beta(3) AR pEC(50) greater than 8; beta(1) and beta(2) AR selectivity greater than 40- and 500-fold, respectively). Our SAR studies suggest that the potency and selectivity profile of the best analogues reported here is a result of both the steric bulk and acidity of the RHS sulfonamide NH group. Although all of the analogues had a pharmacokinetic half-life of less than 2 h, acylsulfonamides 43 and 44 did show moderately low clearance in dogs. These two compounds were further evaluated by thermographic imaging in mice and were found to produce a robust thermogenic response via oral administration.
引用
收藏
页码:567 / 583
页数:17
相关论文
共 50 条
  • [1] Synthesis and evaluation of potent and selective β3 adrenergic receptor agonists containing heterobiaryl carboxylic acids
    Shearer, Barry G.
    Chao, Esther Y.
    Uehling, David E.
    Deaton, David N.
    Cowan, Conrad
    Sherman, Bryan W.
    Milliken, Tula
    Faison, Walter
    Brown, Kathleen
    Adkison, Kimberly K.
    Lee, Frank
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4670 - 4677
  • [2] Synthesis and evaluation of novel phenoxypropanolamine derivatives containing acetanilides as potent and selective β3-adrenergic receptor agonists
    Maruyama, Tatsuya
    Onda, Kenichi
    Hayakawa, Masahiko
    Seki, Norio
    Takahashi, Takumi
    Moritomo, Hiroyuki
    Suzuki, Takayuki
    Matsui, Tetsuo
    Takasu, Toshiyuki
    Nagase, Itsuro
    Ohta, Mitsuaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (09) : 3283 - 3294
  • [3] Synthesis and Evaluation of Novel Phenylethanolamine Derivatives containing Acetanilides as Potent and Selective β3-Adrenergic Receptor Agonists
    Maruyama, Tatsuya
    Onda, Kenichi
    Hayakawa, Masahiko
    Suzuki, Takayuki
    Kimizuka, Tetsuya
    Matsui, Tetsuo
    Takasu, Toshiyuki
    Nagase, Itsuro
    Hamada, Noritaka
    Ohta, Mitsuaki
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2010, 58 (04) : 533 - 545
  • [4] The Synthesis of Two Potent β-3 Adrenergic Receptor Agonists
    Bradley, Paul A.
    Carroll, Robert J.
    Lecouturier, Yann C.
    Moore, Robert
    Noeureuil, Pierre
    Patel, Bhairavi
    Snow, Jonathan
    Wheeler, Simon
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2010, 14 (06) : 1326 - 1336
  • [5] Potent, selective aminothiazolidinediones agonists of the human β3 adrenergic receptor
    Malamas, MS
    Largis, E
    Gunawan, I
    Li, ZN
    Tillett, J
    Han, SCH
    Mulvey, R
    MEDICINAL CHEMISTRY RESEARCH, 2000, 10 (03) : 164 - 177
  • [6] Biarylaniline phenethanolamines as potent and selective β3 adrenergic receptor agonists
    Uehling, DE
    Shearer, BG
    Donaldson, KH
    Chao, EY
    Deaton, DN
    Adkison, KK
    Brown, KK
    Cariello, NF
    Faison, WL
    Lancaster, ME
    Lin, J
    Hart, R
    Milliken, TO
    Paulik, MA
    Sherman, BW
    Sugg, EE
    Cowan, C
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (09) : 2758 - 2771
  • [7] Potent, selective benzenesulfonamide agonists of the human β3 adrenergic receptor
    Weber, AE
    Mathvink, RJ
    Perkins, L
    Hutchins, JE
    Candelore, MR
    Tota, L
    Strader, CD
    Wyvratt, MJ
    Fisher, MH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (09) : 1101 - 1106
  • [8] Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human β3 adrenergic receptor agonists
    Parmee, ER
    Brockunier, LL
    He, JF
    Singh, SB
    Candelore, MR
    Cascieri, MA
    Deng, LP
    Liu, Y
    Tota, L
    Wyvratt, MJ
    Fisher, MH
    Weber, AE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (20) : 2283 - 2286
  • [9] Potent, selective agonists of the human β3-adrenergic receptor.
    Solvibile, WR
    Ashwell, MA
    Molinari, AJ
    Han, S
    Largis, E
    Mulvey, R
    Tillet, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U645 - U645
  • [10] Design, Synthesis, and Evaluation of Conformationally Restricted Acetanilides as Potent and Selective β3 Adrenergic Receptor Agonists for the Treatment of Overactive Bladder
    Moyes, Christopher R.
    Berger, Richard
    Goble, Stephen D.
    Harper, Bart
    Shen, Dong-Ming
    Wang, Liping
    Bansal, Alka
    Brown, Patricia N.
    Chen, Airu S.
    Dingley, Karen H.
    Di Salvo, Jerry
    Fitzmaurice, Aileen
    Gichuru, Loise N.
    Hurley, Amanda L.
    Jochnowitz, Nina
    Miller, Randall R.
    Mistry, Shruty
    Nagabukuro, Hiroshi
    Salituro, Gino M.
    Sanfiz, Anthony
    Stevenson, Andra S.
    Villa, Katherine
    Zamlynny, Beata
    Struthers, Mary
    Weber, Ann E.
    Edmondson, Scott D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (04) : 1437 - 1453